Kathryn Chapman

Executive Director, Innovate Cambridge

A molecular bioscientist, Kathryn has had a distinguished career in diverse leadership and strategic roles across the public and private sectors.

Following a successful research career at the University of Manchester, Harvard Medical School, Wellcome Trust Sanger Institute and GlaxoSmithKline, Chapman has played a pivotal role in shaping inclusive innovation landscapes, building cross-disciplinary virtual and physical communities and creating novel models to remove barriers to success.

This includes a decade building and leading the innovation strategy for NC3Rs, a UKRI Research Council, establishing the Milner Therapeutics Institute at the University of Cambridge to deliver an innovation hub for life sciences and directing the innovation strategy at the Babraham Research Campus.